Sonochemical Induction of ABCA1 Expression and Compositions Therefor
AssigneeSonogene LLC
InventorsEric Coles, Michael Davidson
Life of this patent
Estimating the term…
Loading patent…
AssigneeSonogene LLC
InventorsEric Coles, Michael Davidson
Estimating the term…
The present invention provides compositions useful for transfecting cells (e.g., liver cells) to express ABCA1. The compositions described herein comprise a pharmaceutically acceptable aqueous carrier containing sonochemically-active microspheres together with a plasmid DNA construct encoding an active form of ABCA1 and at least one promoter for the expression thereof. Preferably, the sonochemically-active microspheres comprise, consist essentially of, or consist of gas bubbles (e.g., a fluorocarbon gas, such as octafluoropropane) encapsulated within protein-containing or lipid-containing shells (e.g., human serum albumin shells). The microspheres are disruptable by exposure to ultrasonic acoustic energy to release the encapsulated gas.
A composition useful for transfecting cells comprising a mixture of a plasmid vector encoding an active form of ATP-binding cassette transporter A1 (ABCA1) and sonochemically-active microspheres in a pharmaceutically acceptable aqueous carrier;
A composition useful for transfecting cells comprising a mixture of about 0.5 to about 50 milligrams per milliliter of a plasmid vector encoding an active form of ATP-binding cassette transporter A1 (ABCA1) and about 108 to about 109 microspheres per milliliter of sonochemically-active microspheres in a pharmaceutically acceptable aqueous carrier;
A method of transfecting a tissue in vivo to express an active form of ABCA1 in cells of the tissue, the method comprising the steps of (a) intravenously co-administering to a subject a plasmid vector encoding the active form of ATP-binding cassette transporter A1 (ABCA1), and sonochemically-active microspheres;
Dependencies are inferred from the claim text.